Three-Year Outcomes of Pars Plana Ahmed and Baerveldt Glaucoma Implantations for Neovascular Glaucoma in Japanese Eyes.
Journal
Journal of glaucoma
ISSN: 1536-481X
Titre abrégé: J Glaucoma
Pays: United States
ID NLM: 9300903
Informations de publication
Date de publication:
01 06 2022
01 06 2022
Historique:
received:
02
07
2021
accepted:
30
09
2021
pubmed:
11
10
2021
medline:
7
6
2022
entrez:
10
10
2021
Statut:
ppublish
Résumé
Tube shunt implantation through the pars plana was effective for neovascular glaucoma (NVG) for at least 3 years, with few serious postoperative complications observed. The aim was to report 3-year outcomes of pars plana Ahmed and Baerveldt glaucoma implantation for NVG in Japanese eyes. This study examined 41 eyes of 39 patients who underwent tube shunt implantation through the pars plana with the Baerveldt glaucoma implant (BGI group, 26 eyes) or Ahmed glaucoma valve (AGV group, 15 eyes) for NVG and who were followed up for over 3 years at Osaka Medical College between January 2009 and April 2016. Outcome measures were intraocular pressure (IOP, mm Hg) at presurgery and at 6 months and 1, 2, and 3 years postoperative. Postoperative failure was defined as an IOP of >21 mm Hg or <5 mm Hg, further glaucoma surgery, or no light perception. Mean IOPs at presurgery and at 3 years postoperative were 34.8±9.1 and 15.6±4.6 in the AGV group, and 36.9±9.2 and 12.8±5.5 in the BGI group. Mean antiglaucoma medication scores at 3 years postoperative were 1.3±1.4 in the AGV group and 0.4±0.8 in the BGI group (P=0.05). The number of eyes with a probability of failure at 6 months and at 2 and 3 years postoperative was 2, 3, and 4, respectively, in the BGI group, and 0, 1, and 2, respectively, in the AGV group. Findings for NVG cases showed tube shunt implantation through the pars plana was effective. Equivalent good IOP reductions were noted in both groups, with the BGI group requiring fewer postoperative antiglaucoma medications compared with the AGV group. Furthermore, both groups exhibited few serious postoperative complications.
Identifiants
pubmed: 34628430
doi: 10.1097/IJG.0000000000001953
pii: 00061198-202206000-00015
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
462-467Informations de copyright
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
Disclosure: The authors declare no conflict of interest.
Références
Hayreh SS. Neovascular glaucoma. Prog Retin Eye Res. 2007;26:470–485.
Rodrigues GB, Abe RY, Zangalli C, et al. Neovascular glaucoma: a review. Int J Retina Vitreous. 2016;2:26.
Takihara Y, Inatani M, Fukushima M, et al. Trabeculectomy with mitomycin C for neovascular glaucoma: prognostic factors for surgical failure. Am J Ophthalmol. 2009;147:912–918.
Chilov MN, Grigg JR, Playfair TJ. Bevacizumab (Avastin) for the treatment of neovascular glaucoma. Clin Exp Ophthalmol. 2007;35:494–496.
Costagliola C, Cipollone U, Rinaldi M, et al. Intravitreal bevacizumab (Avastin) injection for neovascular glaucoma: a survey on 23 cases throughout 12-month follow-up. Br J Clin Pharmacol. 2008;66:667–673.
Chen C, Lai I, Wu P, et al. Adjunctive intravitreal bevacizumab-combined trabeculectomy versus trabeculectomy alone in the treatment of neovascular glaucoma. J Ocul Pharmacol Ther. 2010;28:111–118.
Takihara Y, Inatani M, Kawaji T, et al. Combined intravitreal bevacizumab and trabeculectomy with mitomycin C versus trabeculectomy with mitomycin C alone for neovascular glaucoma. J Glaucoma. 2011;20:196–201.
Park UC, Park KH, Kim DM, et al. Ahmed glaucoma valve implantation for neovascular glaucoma after vitrectomy for proliferative diabetic retinopathy. J Glaucoma. 2011;20:433–438.
Luttrul JK, Avery RL. Pars plana implant and vitrectomy for treatment of neovascular glaucoma. Retina. 1995;15:379–387.
Faghihi H, Hajizadeh F, Mohammadi SF, et al. Pars plana Ahmed valve implant and vitrectomy in the management of neovascular glaucoma. Ophthalmic Surg Lasers Imaging. 2007;38:292–300.
Jeong HS, Nam DH, Paik HJ, et al. Pars plana Ahmed implantation combined with 23-gauge vitrectomy for refractory neovascular glaucoma in diabetic retinopathy. Korean J Ophthalmol. 2012;26:92–96.
Ueda T, Hiramatsu R, Zenno M, et al. Long-term clinical outcomes of Baerveldt glaucoma implantation via the pars plana. Nippon Ganka Gakkai Zasshi. 2011;115:581–588.
Aihara M, Abe H, Kitazawa Y, et al. The Japan Glaucoma Society Guidelines for Glaucoma (3rd ed). Nippon Ganka Gakkai Zasshi. 2012;116:3–46.
Mosaed S. Update on aqueous shunts in glaucoma. Int Ophthalmol Clin. 2011;51:155–164.
Kiuchi Y, Sugimoto R, Nakae K, et al. Trabeculectomy with mitomycin C for treatment of neovascular glaucoma in diabetic patients. Ophthalmologica. 2006;220:383–388.
Suda M, Nakanishi H, Akagi T, et al. Baerveldt or Ahmed glaucoma valve implantation with pars plana tube insertion in Japanese eyes with neovascular glaucoma: 1-year outcomes. Clin Ophthalmol. 2018;12:2439–2449.
Tojo N, Hayashi A, Hamada M. Effects of Baerveldt glaucoma implant surgery on corneal endothelial cells of patients with no history of trabeculectomy. Clin Ophthalmol. 2019;13:2333–2340.
Yalvac IS, Eksioglu U, Satana B, et al. Long-term results of Ahmed glaucoma valve and Molteno implant in neovascular glaucoma. Eye. 2007;21:v65–v70.
Nakatake S, Yoshida S, Nakao S, et al. Hyphema is a risk factor for failure of trabeculectomy in neovascular glaucoma: a retrospective analysis. BMC Ophthalmol. 2014;14:55.
Barton K, Gedde SJ, Budenz DL, et al. Ahmed Baerveldt Comparison Study Group. The Ahmed Baerveldt Comparison Study: methodology, baseline patient characteristics, and intraoperative complications. Ophthalmology. 2011;118:435–442.
Christakis PG, Tsai JC, Kalenak JW, et al. The Ahmed Versus Baerveldt Study: three-year treatment outcomes. Ophthalmology. 2013;120:2232–2240.
Gedde SJ, Panarelli JF, Banitt MR, et al. Evidenced based comparison of aqueous shunts. Curr Opin Ophthalmol. 2013;24:87–95.
Heuer DK, Lloyd MA, Abrams DA, et al. Which is better? One or two? A randomized clinical trial of single-plate versus double-plate Molteno implantation for glaucoma in aphakia and pseudophakia. Ophthalmology. 1992;99:1512–1519.
Freedman J, Iserovich P. Pro-inflammatory cytokines in glaucomatous aqueous and encysted Molteno implant blebs and their relationship to pressure. Invest Ophthalmol Vis Sci. 2013;54:4851–4855.
Nguyen Q, Budenz DL, Parrish RK, et al. Complications of Baerveldt glaucoma implants. Arch Ophthalmol. 1998;116:571–575.
Tan AN, Webers CA, Berendschot TT, et al. Corneal endothelial cell loss after Baerveldt glaucoma drainage device implantation in the anterior chamber. Acta Ophthalmol. 2017;95:91–96.
Campagnoli TR, Kim SS, Smiddy WE, et al. Combined pars plana vitrectomy and Baerveldt glaucoma implant placement for refractory glaucoma. Int J Ophthalmol. 2015;8:916–921.
Hamanaka T, Otora K, Ono K, et al. Long-term results of non-valved glaucoma drainage implant surgery and glaucoma drainage implant combined with trabeculectomy. Indian J Ophthalmol. 2014;62:911–916.
McDermott ML, Swendris RP, Shin DH, et al. Corneal endothelial cell counts after Molteno implantation. Am J Ophthalmol. 1993;115:93–96.
Bourne WM, McLaren JW. Clinical responses of the corneal endothelium. Exp Eye Res. 2004;78:561–572.
Nouri-Mahdavi K, Caprioli J. Evaluation of the hypertensive phase after insertion of the Ahmed Glaucoma Valve. Am J Ophthalmol. 2003;136:1001–1008.
Hong CH, Arosemana A, Zurakowski D, et al. Glaucoma drainage device: a systemic literature review and current controversies. Surv Ophthalmol. 2005;50:48–60.
Ayyala RS, Zurakowski D, Smith JA, et al. A clinical study of the Ahmed glaucoma valve implant in advanced glaucoma. Ophthalmology. 1998;105:1968–1976.
Ayyala RS, Duarte JL, Sahiner N. Glaucoma drainage devices: state of the art. Exper Rev Med Devices. 2006;3:509–521.
Chalam KV, Gandham S, Gupta S, et al. Pars plana modified Baerveldt implant versus neodymium:YAG cyclophotocoagulation in the management of neovascular glaucoma. Ophthalmic Surg Lasers. 2002;33:383–393.
Sidoti PA, Dunphy TR, Baerveldt G, et al. Experience with the Baerveldt glaucoma implant in treating neovascular glaucoma. Ophthalmology. 1995;102:1107–1118.
Sidoti PA, Monsny AY, Ritterband DC, et al. Pars plana tube insertion of glaucoma drainage implants and penetrating keratoplasty in patients with coexisting glaucoma and corneal disease. Ophthalmology. 2001;108:1050–1105.
Law SK, Kalenak JW, Connor TB Jr, et al. Retinal complications after aqueous shunt surgical procedures for glaucoma. Arch Ophthalmol. 1996;114:1473–1480.